Traditional cancer treatments like chemotherapy and radiotherapy can induce immunogenic cell death (ICD), but their efficacy ...

COUR Pharma, a clinical-stage biotechnology company developing first-in-class, antigen-specific immune tolerance therapies for autoimmune diseases, announced today it has closed a $50 million Series B ...

Two Danville families are betting big on ostriches as a safe alternative for Alpha-Gal Syndrome sufferers as the tick-borne illness spreads.

Tumor-associated macrophages (TAMs) are immune cells that tumors hijack to fuel their own growth and evade immune attack. A ...

People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a person carries, but also ...

The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

A homeschooling center in Manhattan is part of the company’s nationwide expansion. Internal documents reveal its strategy: “Opening date > safety.” In the fall of 2025, top executives from Alpha ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when you read this story: A scientist wants to reprogram ...

Canadian AI lab Cohere has announced plans to acquire German AI startup Aleph Alpha. Schwarz Group — a key backer of Aleph Alpha — plans to invest $600 million in Cohere's upcoming Series E round as ...

Recent developments in generative artificial intelligence have educators from elementary to university seemingly fighting an uphill battle as they struggle to manage students’ dependence on the ...

AUSTIN, Texas, Jan. 6, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...